Next Gen Biotech

Imatirel tablet contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. This tablet is used in treating adults and children with chronic myeloid leukaemia (CML- it is a form of leukaemia in which certain abnormal white blood cells start growing out of control). It is also indicated to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph-positive ALL). It is also used to treat certain types of gastrointestinal stromal tumours (GIST, a kind of tumour that grows in the walls of the digestive passages and may spread to other parts of the body) 

Imatirel tablet is also used to treat myelodysplastic/myeloproliferative diseases (MDS/MPD). These are a group of blood diseases in which some blood cells start growing out of control. They also treat hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukaemia (CEL); these are blood diseases in which some blood cells (eosinophils) start growing out of control. This medicine is also intended to treat dermatofibrosarcoma protuberans (DFSP), a cancer of the tissue beneath the skin in which some cells start growing abnormally. It works, inhibiting the growth of these abnormal blood cells. 

Do not take the Imatirel tablet if you are allergic to imatinib or any other ingredients in this medicine. Before initiating the treatment, inform your physician if you have kidney, heart or liver problems, if you have thyroid problems, or if your thyroid gland has been removed. Notify your doctor if you ever had or have a hepatitis B infection because this medicine could cause the hepatitis B to become active again. Report any symptoms of bruising, bleeding, fever, fatigue and confusion when taking this medicine. This medicine may cause fertility problems.  

Imatinate 400mg Capsule is an antineoplastic (anti-cancer) medication classified as a tyrosine kinase inhibitor. It is primarily used to treat:

• Chronic Myeloid Leukemia (CML): A type of blood cancer where abnormal white blood cells proliferate uncontrollably.

• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): A subtype of acute lymphoblastic leukemia characterized by the presence of the Philadelphia chromosome.

• Gastrointestinal Stromal Tumors (GIST): Tumors originating in the digestive tract walls that may metastasize.

• Myelodysplastic/Myeloproliferative Diseases (MDS/MPD): A group of disorders caused by abnormal blood cell production in the bone marrow.

• Hypereosinophilic Syndrome (HES) and Chronic Eosinophilic Leukemia (CEL): Conditions marked by the overproduction of eosinophils, a type of white blood cell.

• Dermatofibrosarcoma Protuberans (DFSP): A rare cancer of the deeper layers of the skin.

Imatinib, the active component, works by inhibiting specific tyrosine kinases, thereby preventing the proliferation of cancer cells. Common side effects include edema, nausea, vomiting, muscle cramps, musculoskeletal pain, diarrhea, rash, fatigue, and abdominal pain. Regular monitoring of blood counts and liver function is recommended during treatment. It's essential to take this medication with food to reduce gastrointestinal discomfort and adhere to the prescribed dosage regimen.

Imatib 400 mg contains Imatinib Mesylate, a tyrosine kinase inhibitor used in the treatment of certain types of cancer, including chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GISTs). It works by blocking the abnormal protein that signals cancer cells to multiply, thereby slowing or stopping their growth.

Researchers have developed a new type of radiotherapy called Intensity Modulated Arc Therapy (IMAT). This allows radiotherapy to be directed more accurately at the cancer. Doctors think that using IMAT means a higher dose of radiotherapy can be given so the treatment might be better at killing the cancer cells.

Additional Information:

• Delivery Time: 1 day

Veenat 100mg Capsule is an antineoplastic (anti-cancer) medication classified as a tyrosine kinase inhibitor. It is primarily used to treat:

• Chronic Myeloid Leukemia (CML): A type of blood cancer where abnormal white blood cells proliferate uncontrollably.

• Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): A subtype of acute lymphoblastic leukemia characterized by the presence of the Philadelphia chromosome.

• Gastrointestinal Stromal Tumors (GIST): Tumors originating in the walls of the digestive tract.

• Myelodysplastic/Myeloproliferative Diseases (MDS/MPD): A group of blood disorders where some blood cells grow uncontrollably.

• Hypereosinophilic Syndrome (HES) and Chronic Eosinophilic Leukemia (CEL): Conditions marked by the overproduction of eosinophils, a type of white blood cell.

• Dermatofibrosarcoma Protuberans (DFSP): A rare cancer of the tissue beneath the skin.

Imatinib, the active component, works by inhibiting specific tyrosine kinases, thereby preventing the proliferation and spread of cancer cells. Common side effects include nausea, vomiting, diarrhea, muscle cramps, joint pain, fatigue, and skin rash. It's essential to take this medication with food to reduce gastrointestinal discomfort and adhere to the prescribed dosage regimen. Regular monitoring of blood counts and liver function is recommended during treatment.